Finally, they constitute an original family of allosteric modulators with far reaching potential medical applications such as cognitive enhancers, or as a potential treatment against α7-nAChR auto-antibodies that are found in some patients diagnosed with schizophrenia [39]. Here, CHRNA7 is linked to schizophrenia.